Commercialization Bridge

Bridging the Gap from Discovery to Market.

We accelerate the commercialization and adoption of genomics by funding public-private partnerships that turn research excellence into competitive products and services.

Canada generates world-class genomics research, but this research only creates economic and societal value when it is translated into real-world products, services and practices.

Without strong public-private partnerships, too much innovation stalls before reaching the market. The Genomic Applications Partnership Program (GAPP) is our national mechanism to bridge this divide. By funding collaborative R&D projects between academic researchers and industry receptors, we share the risk and leverage private-sector investment to turn discovery into application. This approach ensures that genomics strengthens Canada’s innovation economy and delivers tangible solutions to our most pressing challenges.

supervisors-check

Mission At A Glance

Projects start with a real operational need

Companies identify where genomics can be applied in their business.

Researchers and companies build together

Scientific expertise is applied directly to a defined use case.

Developed and validated 
in practice

Technologies are trialed within operational settings, not just labs.

Solutions are implemented, not shelved

Projects are designed to move into use within the partner organization.

GAPP shifts the focus from basic research outputs to delivered real-world solutions through strategic ecosystem orchestration.

Market-Driven Innovation

Ensuring projects are driven by real market or operational needs identified by industry receptors to ensure high-value outcomes.

Risk-Sharing and Leverage

Using public investment to catalyze private-sector co-investment and shorten the path from innovation to market.

Productivity and Growth

Helping Canadian companies integrate genomics tools into their operations to boost productivity, reduce costs and drive sustainable growth.

Strategic Deployment

Serving as a core delivery mechanism for commercialization and adoption under the Canadian Genomics Strategy.

National Strategy.
 Regional Excellence.

We leverage the unique expertise of our regional Genome Centres to mobilize surveillance capabilities nationwide. This strategic orchestration ensures that genomic signals from every corner of Canada, from Arctic waters to urban centers, are connected to a unified national preparedness strategy. We turn distributed environmental data into a collective national advantage.

British Columbia


Clinical implementation and sequencing programs contributing to national dataset.

Alberta


Clinical implementation and sequencing programs contributing to national dataset.

Manitoba Canada


Clinical implementation and sequencing programs contributing to national dataset.

Ontario


Clinical implementation and sequencing programs contributing to national dataset.

Quebec


Clinical implementation and sequencing programs contributing to national dataset.

New Brunswick


Clinical implementation and sequencing programs contributing to national dataset.

Turning Discovery 
into Durable Economic Advantage.

Genomics underpins innovation in life sciences, agri-food, natural resources and advanced manufacturing where Canada already holds global strengths.

Rectangle 10 Strategic genomics investment is the essential economic infrastructure for the twenty-first-century bioeconomy.

Rectangle 10 Rectangle 11 By focusing on adoption and market uptake, we help Canadian firms grow and commercialize at home rather than abroad to capture a share of the expanding global genomics market.

Missions in Action: 
 Translation and Impact.

Current Project

Community driven microbe sequencing and naming in Pictou Landing First Nation

Meredith Karcz (Confederacy of Mainland Mi’kmaq), Casey Hubert (University of Calgary), James Kho (Dalhousie University)

Current Project

Indigenous-Led Genomics Curriculum for One Health and Climate Resilience in the North

Math’ieya Alatini (One Yukon Coalition)

Current Project

Pan-Canadian Human Genome Library for Canadian Precision Health Initiative

Guillaume Bourque (McGill University) and Ma’n Zawati (McGill University)

A National Coalition for Commercialization.

Mission success depends on the collective capacity of Canada’s industry, academia and government partners.

Strategic Partners

Mission Control: Join the Bio-Revolution.

Subscribe to receive actionable intelligence on the genomics missions shaping Canada’s future.

This field is for validation purposes and should be left unchanged.
Interests

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.